Alkim Alkali Kimya AS
IST:ALKIM.E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alkim Alkali Kimya AS
IST:ALKIM.E
|
TR |
|
CNBX Pharmaceuticals Inc
OTC:CNBX
|
US |
|
Bindal Exports Ltd
BSE:540148
|
IN |
|
Kukje Pharma Co Ltd
KRX:002720
|
KR |
Cash Flow Statement
Cash Flow Statement
Alkim Alkali Kimya AS
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||
| Net Income |
216
|
231
|
216
|
181
|
285
|
370
|
544
|
705
|
668
|
592
|
550
|
596
|
289
|
91
|
(1)
|
(252)
|
(165)
|
(146)
|
(185)
|
(214)
|
(430)
|
|
| Depreciation & Amortization |
22
|
23
|
22
|
23
|
24
|
26
|
29
|
32
|
152
|
33
|
33
|
33
|
201
|
172
|
211
|
260
|
268
|
219
|
235
|
250
|
266
|
|
| Other Non-Cash Items |
33
|
40
|
40
|
36
|
64
|
109
|
140
|
188
|
880
|
220
|
190
|
175
|
206
|
279
|
91
|
100
|
305
|
330
|
312
|
264
|
392
|
|
| Cash Taxes Paid |
44
|
41
|
41
|
36
|
25
|
64
|
98
|
145
|
413
|
170
|
155
|
143
|
248
|
153
|
184
|
145
|
54
|
41
|
(7)
|
(8)
|
20
|
|
| Cash Interest Paid |
3
|
2
|
4
|
5
|
0
|
1
|
1
|
2
|
11
|
5
|
6
|
7
|
24
|
20
|
16
|
20
|
11
|
5
|
9
|
11
|
31
|
|
| Change in Working Capital |
(171)
|
(62)
|
(236)
|
(170)
|
(8)
|
(161)
|
(144)
|
(514)
|
(1 558)
|
(578)
|
(348)
|
(306)
|
180
|
(168)
|
(335)
|
(1)
|
(366)
|
(256)
|
(281)
|
(101)
|
123
|
|
| Cash from Operating Activities |
101
N/A
|
231
+129%
|
42
-82%
|
70
+66%
|
365
+423%
|
344
-6%
|
568
+65%
|
411
-28%
|
(232)
N/A
|
267
N/A
|
426
+59%
|
498
+17%
|
1 005
+102%
|
375
-63%
|
(34)
N/A
|
106
N/A
|
(8)
N/A
|
148
N/A
|
81
-45%
|
199
+145%
|
351
+76%
|
|
| Investing Cash Flow | ||||||||||||||||||||||
| Capital Expenditures |
(19)
|
(90)
|
(63)
|
(110)
|
(146)
|
(76)
|
(106)
|
(76)
|
(199)
|
(131)
|
(136)
|
(132)
|
(188)
|
(172)
|
(323)
|
(423)
|
(895)
|
(803)
|
(873)
|
(955)
|
(840)
|
|
| Other Items |
1
|
1
|
0
|
0
|
57
|
58
|
62
|
63
|
15
|
11
|
(14)
|
(16)
|
(198)
|
(167)
|
(122)
|
(208)
|
496
|
374
|
369
|
467
|
46
|
|
| Cash from Investing Activities |
(18)
N/A
|
(89)
-387%
|
(63)
+29%
|
(110)
-74%
|
(89)
+19%
|
(18)
+79%
|
(43)
-135%
|
(13)
+70%
|
(184)
-1 342%
|
(120)
+35%
|
(150)
-25%
|
(148)
+2%
|
(386)
-161%
|
(339)
+12%
|
(446)
-31%
|
(631)
-42%
|
(399)
+37%
|
(429)
-8%
|
(504)
-18%
|
(489)
+3%
|
(794)
-62%
|
|
| Financing Cash Flow | ||||||||||||||||||||||
| Net Issuance of Debt |
(17)
|
(13)
|
(12)
|
(37)
|
0
|
(14)
|
44
|
42
|
(55)
|
(72)
|
(93)
|
(70)
|
(42)
|
(21)
|
39
|
(25)
|
41
|
62
|
154
|
236
|
110
|
|
| Cash Paid for Dividends |
(23)
|
(79)
|
(81)
|
(81)
|
(136)
|
(80)
|
(126)
|
(126)
|
(59)
|
(161)
|
(162)
|
(162)
|
(341)
|
(215)
|
(74)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
2
|
3
|
2
|
(0)
|
3
|
1
|
1
|
(0)
|
11
|
10
|
14
|
19
|
(24)
|
4
|
42
|
37
|
(11)
|
5
|
(45)
|
(52)
|
(31)
|
|
| Cash from Financing Activities |
(39)
N/A
|
(89)
-128%
|
(91)
-2%
|
(118)
-30%
|
(133)
-13%
|
(93)
+31%
|
(81)
+13%
|
(83)
-3%
|
(103)
-23%
|
(222)
-116%
|
(241)
-8%
|
(212)
+12%
|
(407)
-92%
|
(232)
+43%
|
6
N/A
|
(63)
N/A
|
29
N/A
|
67
+128%
|
108
+62%
|
183
+69%
|
79
-57%
|
|
| Change in Cash | ||||||||||||||||||||||
| Net Change in Cash |
43
N/A
|
53
+22%
|
(112)
N/A
|
(158)
-42%
|
143
N/A
|
233
+63%
|
444
+91%
|
315
-29%
|
(519)
N/A
|
(75)
+86%
|
35
N/A
|
138
+299%
|
212
+53%
|
(196)
N/A
|
(473)
-141%
|
(588)
-24%
|
(378)
+36%
|
(214)
+43%
|
(314)
-47%
|
(106)
+66%
|
(365)
-243%
|
|
| Free Cash Flow | ||||||||||||||||||||||
| Free Cash Flow |
82
N/A
|
141
+73%
|
(21)
N/A
|
(40)
-87%
|
219
N/A
|
268
+23%
|
463
+73%
|
336
-27%
|
(431)
N/A
|
136
N/A
|
290
+114%
|
366
+26%
|
817
+123%
|
202
-75%
|
(357)
N/A
|
(317)
+11%
|
(903)
-185%
|
(655)
+27%
|
(791)
-21%
|
(756)
+4%
|
(489)
+35%
|
|